Request Deal Involvement

Genmab to acquire Merus for $8bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Latham & Watkins

legal advisors

Latham & Watkins

NautaDutilh

legal advisors

NautaDutilh

PJT Partners

financial advisors

PJT Partners

Kromann Reumert

legal advisors

Kromann Reumert

A&O Shearman

legal advisors

A&O Shearman

Morgan Stanley

financial advisors

Morgan Stanley

or

Principals

MERUS B.V.

target

MERUS B.V.

GENMAB AS

bidder

GENMAB AS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Genmab to acquire Merus for $8bn.